Features of the course and treatment of acute stroke in patients with diabetes mellitus

О. А. Галушко


Diabetes mellitus (DM) is one of the causes and an important risk factor for acute stroke (AS), and a stroke, in turn, is one of the causes of the development of decompensation of DM.

The objective: to analyze the peculiarities of the course and treatment of AS in patients with DM and other carbohydrate metabolism disorders.

Materials and methods. A retrospective analysis of the disease histories was carried out on 416 patients with AS. Patients were studied in three groups: 1) diabetic patients with AS, 2) patients with the first detected diabetes and 3) patients without diabetes.

Results. In patients with diabetes, ischemic stroke was significantly prevalent (107 out of 110 patients, or 97.3%). Cases of hemorrhagic AS in these patients were isolated and practically casuistic. Patients hospitalized in the intensive care unit (ICU) had a course ranging from moderate to extremely severe (scores for NIHSS ranged from 9 to 18, with a maximum of 34 points). Neuroprotectors were intended for almost all (99.6%) patients with acute stroke, starting from 1–2 days. In some cases, 2–3 neuroprotectors were prescribed at a time. The main reason for the repeated transfer of patients to the ICU by 2–3 and 8–9 days was a violation of external breathing.

Conclusions. As a result of the analysis of treatment of diabetic patients with AS, it was determined that the following directions of intensive care of these patients should be improved: 1) detection and diagnosis of diabetes and occult forms of carbohydrate metabolism disorders; 2) diagnostics, monitoring and correction of respiratory disorders; 3) infusion therapy (fluid balance, choice of solutions)


acute stroke; diabetes mellitus; decompensation; respiratory failure; intensive care


Сучасні принципи діагностики та лікування хворих із гострим ішемічним інсультом та ТІА (Адаптована клінічна настанова) – К.: Видавець Д.В. Гуляєв, 2012. – 144 с.

Gaede P, Lund Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008 Feb 7;358(6):580 91. doi: 10.1056/NEJ-Moa-0706245. PubMed PMID: 18256393.

Burchfiel CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K. Glucose intolerance and 22 year stroke incidence. The Honolulu Heart Program. Stroke. 1994 May; 25(5):951–7. PubMed PMID: 8165689.

Осложнения и последствия инсультов. Диагностика и лечение ранних и поздних нарушений функции / под ред. Г.Я. Юнгехюльзинга, М. Єндреса; пер. с нем. Под ред. Л.В. Стаховской. – М.: МЕДпресс информ, 2017. – 264 с.

Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta analysis. Stroke. 2011 May; 42(5): 1489 94. doi: 10.1161/STROKEA-HA.110.602615. Epub 2011 Mar 31. Review. PubMed PMID: 21454819.

Copyright (c) 2020 О. А. Галушко

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN 2412-8708 (Online), ISSN 2307-5112 (Print)

Flag Counter

ISSN (print): 2307-5112.